Cargando…

The logistics of broader pre-clinical evaluation of potential anti-cancer agents with reference to anti-tumour activity and toxicity of mitozolomide.

Anti-tumour responses with CCRG81010, M & B 39565, NSC 353451, 8-carbamoyl-3-(2-chloroethyl)imidazo [5,1-d]-1,2,3,5-tetrazin-4(3H)-one (Mitozolomide) in a panel of 4 murine colon tumours of varying growth characteristics and chemosensitivity and a spontaneous murine lymphoma are similar to those...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bibby, M. C., Double, J. A., Wahed, I. A., Hirbawi, N., Baker, T. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1988
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246776/ https://www.ncbi.nlm.nih.gov/pubmed/3166903

Ejemplares similares

Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.
por: Bibby, M. C., et al.
Publicado: (1981)

Plasma and tissue disposition of mitozolomide in mice.
por: Brindley, C. J., et al.
Publicado: (1986)

The effects of pretreatment of human tumour cells with MNNG on the DNA crosslinking and cytotoxicity of mitozolomide.
por: Gibson, N. W., et al.
Publicado: (1985)

Phase II evaluation of mitozolomide in ovarian cancer.
por: Harding, M., et al.
Publicado: (1988)

Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent
por: Patterson, L H, et al.
Publicado: (2000)

Mitozolomide activity on human cancer cells in vitro.
por: Erba, E., et al.
Publicado: (1986)

Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985)

Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
por: Double, J. A., et al.
Publicado: (1986)

The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.
por: Bibby, M. C., et al.
Publicado: (1991)

Mitozolomide-induced sensitisation of mammalian cells in vitro to radiation.
por: McKeage, M. J., et al.
Publicado: (1989)

Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
por: Bibby, M. C., et al.
Publicado: (1991)

Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
por: Bibby, M. C., et al.
Publicado: (1987)

Selectivity and potency; are we doing the right things to find anti-cancer agents with these properties?
por: Double, J. A.
Publicado: (1992)

Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
por: Bibby, M. C., et al.
Publicado: (1988)

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311
por: Burger, A M, et al.
Publicado: (1999)

Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
por: Gundersen, S., et al.
Publicado: (1987)

The Sensitivity to Chemotherapeutic Agents of a Rat Tumour Grown in Immunosuppressed Mice
por: Sheard, Christine E., et al.
Publicado: (1971)

Acridine as an Anti-Tumour Agent: A Critical Review
por: Varakumar, Potlapati, et al.
Publicado: (2022)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Broad, broader, broadest
por: van Nunen, L.X., et al.
Publicado: (2015)

Broad, broader, broadest
por: van Nunen, L.X., et al.
Publicado: (2015)

Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
por: Ohnishi, M., et al.
Publicado: (1994)

Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine.
por: Stratford, I. J., et al.
Publicado: (1988)

A Broader Perspective on Anti-Ro Antibodies and Their Fetal Consequences—A Case Report and Literature Review
por: Popescu, Mihaela Roxana, et al.
Publicado: (2020)

Characterisation and chemosensitivity of a well-differentiated murine transplantable adenocarcinoma of the colon.
por: Double, J. A., et al.
Publicado: (1983)

A Broader View
por: Goehl, Thomas J.
Publicado: (1996)

Broader horizons ahead
por: CERN Bulletin
Publicado: (2010)

Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.
por: Iwadate, Y., et al.
Publicado: (1998)

Pre-clinical studies of a novel anti-mitotic agent, amphethinile.
por: McGown, A. T., et al.
Publicado: (1988)

Influence of O(6)-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice
por: Bibby, M C, et al.
Publicado: (1999)

A Systematic Comparison of the Anti-Tumoural Activity and Toxicity of the Three Adv-TKs
por: Gao, Qinglei, et al.
Publicado: (2014)

A Case Report: Anti-Psychotic Agents Related Ocular Toxicity
por: Choy, Bonnie Nga Kwan, et al.
Publicado: (2016)

Broader impacts of science on society
por: MacFadden, Bruce J
Publicado: (2019)

The broader context of medical ethics
por: Dekkers, Wim, et al.
Publicado: (2008)

Systems Biology — the Broader Perspective
por: Bard, Jonathan
Publicado: (2013)

Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours
por: Yoo, Changhoon, et al.
Publicado: (2019)

Pre-clinical evaluation of a novel chloroethylating agent, Clomesone.
por: Matthew, A. M., et al.
Publicado: (1993)

A broader vision : perspectives on the Buddha and the Christ
por: Drummond, Richard Henry

Anti-tumour Activity of Aprotinin
por: Latner, A. L., et al.
Publicado: (1974)

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
por: Qiu, L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_qfcvvqif6qo5cbipatflks9aua